Evan Smith
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Inflammatory mediators and NSAID effects 2
- Treatment of Major Depression 2
- Alkaloids: synthesis and pharmacology 2
-
- Chemical synthesis and alkaloids 2
- Co-authors
- Deepak Dalvie (5 shared papers)Ping Kang (4 shared papers)Cho‐Ming Loi (2 shared papers)Alan Deese (3 shared papers)Haig Bozigian (4 shared papers)Sam R.J. Hoare (1 shared paper)Ajay Madan (2 shared papers)Dimitri E. Grigoriadis (2 shared papers)
- Journals
- Drug Metabolism and Disposition (4 papers)Neurology (3 papers)Chemical Research in Toxicology (2 papers)Bioorganic & Medicinal Chemistry Letters (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Evan Smith
14 papers receiving 496 citations
Peers
Comparison fields: 5 of 77
- Pharmacology 259
- Biochemistry 88
- Pharmacology 64
- Oncology 89
- Pharmaceutical Science 19
Countries citing papers authored by Evan Smith
This map shows the geographic impact of Evan Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Smith more than expected).
Fields of papers citing papers by Evan Smith
This network shows the impact of papers produced by Evan Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Smith. The network helps show where Evan Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 149 | |
| 2 | 2012 | 81 | |
| 3 | 2017 | 75 | |
| 4 | 2008 | 47 | |
| 5 | 2008 | 41 | |
| 6 | 2013 | 38 | |
| 7 | 2007 | 35 | |
| 8 | Pharmacokinetics of monoamine oxidase inhibitors. | 1991 | 28 |
| 9 | 2006 | 18 | |
| 10 | 2012 | 3 | |
| 11 | 2020 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 1988 | 1 |
About Evan Smith
Evan Smith is a scholar working on Pharmacology, Pharmacology, Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience, having authored 14 papers that have together received 519 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Inflammatory mediators and NSAID effects (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Chemical synthesis and alkaloids (2 papers), Treatment of Major Depression (2 papers), Alkaloids: synthesis and pharmacology (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). The work is most often cited by research in Pharmacology (259 citations), Biochemistry (88 citations), Pharmacology (64 citations), Oncology (89 citations) and Pharmaceutical Science (19 citations). Evan Smith has collaborated with scholars based in United States. Frequent co-authors include Deepak Dalvie, Ping Kang, Cho‐Ming Loi, Alan Deese, Haig Bozigian, Sam R.J. Hoare, Ajay Madan, Dimitri E. Grigoriadis, R. Scott Obach and Chandra Prakash. Their work appears in journals such as Drug Metabolism and Disposition, Neurology, Chemical Research in Toxicology, Bioorganic & Medicinal Chemistry Letters and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.